55
Views
15
CrossRef citations to date
0
Altmetric
Original Research

The prognostic value of neutrophil–lymphocyte ratio is superior to derived neutrophil–lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up

, , , , , , & show all
Pages 2655-2664 | Published online: 22 May 2017

References

  • FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
  • IsobeYNashimotoAAkazawaKGastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registryGastric Cancer201114430131621894577
  • CunninghamDAllumWHStenningSPPerioperative chemotherapy versus surgery alone for resectable gastroesophageal cancerN Engl J Med20063551112016822992
  • BalkwillFMantovaniAInflammation and cancer: back to Virchow?Lancet2001357925553954511229684
  • CoussensLMWerbZInflammation and cancerNature2002420691786086712490959
  • HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
  • MaltoniMCaraceniABrunelliCPrognostic factors in advanced cancer patients: evidence-based clinical recommendations – a study by the Steering Committee of the European Association for Palliative CareJ Clin Oncol200523256240624816135490
  • ProctorMJMorrisonDSTalwarDA comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome StudyEur J Cancer201147172633264121724383
  • ProctorMJMcMillanDCMorrisonDSFletcherCDHorganPGClarkeSJA derived neutrophil to lymphocyte ratio predicts survival in patients with cancerBr J Cancer2012107469569922828611
  • GuthrieGJCharlesKARoxburghCSHorganPGMcMillanDCClarkeSJThe systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancerCrit Rev Oncol Hematol201388121823023602134
  • ParamanathanASaxenaAMorrisDLA systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumoursSurg Oncol2014231313924378193
  • PanQXSuZJZhangJHWangCRKeSYA comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancerOnco Targets Ther201581375138526124667
  • AbsengerGSzkanderaJPichlerMA derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patientsBr J Cancer2013109239540023820252
  • SzkanderaJStotzMEisnerFExternal validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patientsPLoS One2013811e7822524223776
  • DiricanAEkinciNAvciAThe effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancerCancer Biomark2013131112023736017
  • DiricanAKucukzeybekBBAlacaciogluADo the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?Int J Clin Oncol2015201708124532163
  • AzabBBhattVRPhookanJUsefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patientsAnn Surg Oncol201219121722421638095
  • ChuaWCharlesKABaracosVEClarkeSJNeutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancerBr J Cancer201110481288129521448173
  • NobleFHopkinsJCurtisNThe role of systemic inflammatory and nutritional blood-borne markers in predicting response to neoadjuvant chemotherapy and survival in oesophagogastric cancerMed Oncol201330359623690267
  • LeeSOhSYKimSHPrognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapyBMC Cancer20131335023876227
  • JinHZhangGLiuXBlood neutrophil-lymphocyte ratio predicts survival for stage III–IV gastric cancer treated with neoadjuvant chemotherapyWorld J Surg Oncol20131111211023281640
  • LuoGGuoMLiuZBlood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapyAnn Surg Oncol201522267067625155401
  • KaoSCPavlakisNHarvieRHigh blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapyClin Cancer Res201016235805581320956618
  • WashingtonK7th edition of the AJCC cancer staging manual: stomachAnn Surg Oncol201017123077307920882416
  • SasakiAIwashitaYShibataKMatsumotoTOhtaMKitanoSPrognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinomaSurgery2006139675576416782430
  • LeeYYChoiCHSungCOPrognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag levelGynecol Oncol20121241929722014631
  • JablonskaEPuzewskaWGrabowskaZJablonskiJTalarekLVEGF, IL-18 and NO production by neutrophils and their serum levels in patients with oral cavity cancerCytokine2005303939915826815
  • ArdiVCKupriyanovaTADeryuginaEIQuigleyJPHuman neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesisProc Natl Acad Sci U S A200710451202622026718077379
  • MotomuraTShirabeKManoYNeutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironmentJ Hepatol2013581586422925812
  • KantolaTKlintrupKVayrynenJPStage-dependent alterations of the serum cytokine pattern in colorectal carcinomaBr J Cancer2012107101729173623059742